PATENT CLAIM ANALYSIS

Application Number: 16276173
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["530", "391900"]

Abstract:
The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates.

Claim (Index 14):
The method of  claim 1 , wherein said MAb is attached to between 1 and 12 copies of the linker-SN38.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15587526', '16045400', '15133675', '15267910', '14636790']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7268447199503663
- 35 USC 102 Novelty (BERT): 0.5826917990374981
- Combined Prediction Score: 0.7124294278590795
- Mean Citation Score: 457.71055400000006
- Max Citation Score: 471.42065
- Similarity Product: 438.56164597605766

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test